All News

Urate lowering therapy indications for #Gout:
- Tophi
- Frequent flares ( ≥ 2/yr)
- Chronic kidney disease
- Hx of renal stones
Will these change in the 2019 guidelines?
#ACR19 @RheumNow
Kanika Monga, MD DrKanikaMonga ( View Tweet)

🤳My first ever selfie video series -- I ask the experts for some twitter advice! Come tag along with me :)
#ACR19 @RheumNow @ACRheum @UTHealth
Kanika Monga, MD DrKanikaMonga ( View Tweet)

Retrospective review of 236 RA pts and 166 pts w/other systemic diseases who received Shingrix: no significant increase risk in disease flare or vaccine-related AEs. Abstr#1804 #ACR19 #whyivaccinate @RheumNow @LCalabreseDO @BetsyKirch
Cassandra Calabrese CCalabreseDO ( View Tweet)

Abstr#1802 - nice study from @CleClinicMD confirming low clinical value of annual quantiferon screening for LTBI in the absence of new or ongoing risk factor #ACR2019 @RheumNow @ElaineHusniMD #cleclinicrheum
Cassandra Calabrese CCalabreseDO ( View Tweet)

Abstr#1806: Another centre’s experience with IA-irAEs from ICIs #ACR19 @RheumNow https://t.co/OFZaYqMSFR
Maeve Gamble MaeveGamble ( View Tweet)

Don’t forget to check immunoglobulins prior to starting Rituximab! Thanks for sharing our results! @hausmannMD #ACR19 @RheumNow https://t.co/PNGe72waez
Stefanie D Wade, MD doctorswade ( View Tweet)

Beware hydralazine! Associated vasculitis with high frequency of CKD and poor outcomes. 100%renal involvement and ANCA positivity! Abstr#1667 @SajaAlmaaitah @kinanah9 @CleClinicMD #cleclinicrheum #ACR19 @RheumNow https://t.co/qJM49xN6Rx
Cassandra Calabrese CCalabreseDO ( View Tweet)

Abstr#824 VERVE results - safety of live heroes zoster vaccine in pts on TNFi- no cases of vaccine-related varicella @LCalabreseDO @BetsyKirch @RheumNow #ACR19 #cleclinicrheum https://t.co/zPDvQujgzP
Cassandra Calabrese CCalabreseDO ( View Tweet)

Excellent irAE summary by Ryan Sullivan -judicious use of steroids, High doses when needed, low dose when possible. Pre-existing AID not a contradiction to checkpoint inhibitor Tx! @RheumNow @LCalabreseDO @cappelliMD @lexmeara #ACR19 #cleclinicrheum https://t.co/TOTXQzxXhp
Cassandra Calabrese CCalabreseDO ( View Tweet)

Do you co-manage your PsO/PsA patients with dermatology? #ACR19 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)

So glad that our clinical study from @RBNHSFT looking at the outcome measures in Axial Spondyloarthritis eg. BASDAI, ASDAS, CRP, BASFI and the impact on response to treatment was delivered today as an oral presentation with good feedback at #ACR19 #axialspondyloarthritis
Dr. Antoni Chan synovialjoints ( View Tweet)

Continued Ixekizumab was superior to PBO in maintaining MDA in biologic-naïve PsA pts who achieved sustained MDA on initial IXE treatment. A vast majority of pts who lost MDA after IXE withdrawal regained MDA with IXE re-treatment presented by @DrLauraCoates #ACR19 @RheumNow
Dr. Antoni Chan synovialjoints ( View Tweet)

Relapsing Polychondritis: a 4th more worrying phenotype
#ACR19 @rheumnow 4M086 https://t.co/4EAgBb07cV
Dr Irwin Lim _connectedcare ( View Tweet)

Relapsing Polychondritis: 3 more common clinical phenotypes
#ACR19 @rheumnow 4M086 https://t.co/aqNQMYCao2
Dr Irwin Lim _connectedcare ( View Tweet)

Relapsing Polychondritis: speaker’s recommendations
#ACR19 @rheumnow 4M086 https://t.co/G2TIOfTGiW
Dr Irwin Lim _connectedcare ( View Tweet)

What’s your first line therapy for AS? Write below if you use something else!
@RheumNow #ACR19
Dr. Rachel Tate uptoTate ( View Tweet)

@RheumNow What is your primary pharmacotherapy for inflammatory-type erosive hand OA?
#ACR19 @RheumNow Plenary II ABST1759/1760
David Liew drdavidliew ( View Tweet)

FRAME study results: Romo increases MBBF on the Ec and Cn surfaces which stimulates bone formation during first 2 months of tx. https://t.co/qmbyt8w75Q #abs1874 #ACR19 @RheumNow https://t.co/FQIIU8kcsp
Dr. Rachel Tate uptoTate ( View Tweet)

#acrbest @rheumnow #acr19 abstr#1901
VERY IMPT STUDY: 16,490 offspring of moms w/Rheum Dz: 105 on nonTNFi biologic or TOFA:
NO ⬆️in utero SIE . Only 2 cases of SIE- 1 w/TOFA &1 w/ABT.
Risk for SIE in utero
For healthy 1.6%
For TNFi 2.3%
For nonTNFi + TOFA 2.1%
k dao KDAO2011 ( View Tweet)

SLE has high work disability. Interestingly work disability was not high in some organ systems such as renal but mild GN or CRF may not be symptomatic. Fibromyalgia, low education, low SED and older age increase work disability ACR219 @RheumNow abstr 1578 https://t.co/DdHgluRPIV
Janet Pope Janetbirdope ( View Tweet)